Methods for in vitro susceptibility testing of chlamydia
US6258532A · kind A · utility
6Cited by
7References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 18, 1998 |
| Grant date | Jul 10, 2001 |
| Priority date | — |
| Expiry date | Feb 18, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/455
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for determining the susceptibility of intracellular pathogens, particularly Chlamydia, to single or combination of test agents are described. The methods can be used for in vitro or in vivo evaluation of agents that can be used as therapeutic agents in the treatment/eradication of pathogen infection in general or to target a specific infected organ. Assays which utilize nucleic amplification techniques (e.g., PCR) to determine effectiveness of the agent(s) evaluated are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.